NO994902L - Forebygging av brystkreft ved selektive östrogenreseptormodulatorer - Google Patents

Forebygging av brystkreft ved selektive östrogenreseptormodulatorer

Info

Publication number: NO994902L
Authority: NO; Norway
Prior art keywords: breast cancer; estrogen receptor; receptor modulators; selective estrogen; cancer prevention
Prior art date: 1997-04-09

Application number

NO994902A

Other languages

English (en)

Norwegian (no)

Other versions

NO994902D0 (no

Inventor

Andrew Lawrence Glasebrook

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-04-09

Filing date

1999-10-08

Publication date

1999-12-07

1999-10-08 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

1999-10-08 Publication of NO994902D0 publication Critical patent/NO994902D0/no

1999-12-07 Publication of NO994902L publication Critical patent/NO994902L/no

Links

206010006187 Breast cancer Diseases 0.000 title abstract 3
208000026310 Breast neoplasm Diseases 0.000 title abstract 3
230000002265 prevention Effects 0.000 title 1
239000000333 selective estrogen receptor modulator Substances 0.000 title 1
229940095743 selective estrogen receptor modulator Drugs 0.000 title 1
-1 pyrrolidino, methylpyrrolidino, dimethylpyrrolidino, piperidino, morpholino Chemical group 0.000 abstract 2
125000003545 alkoxy group Chemical group 0.000 abstract 1
201000008275 breast carcinoma Diseases 0.000 abstract 1
125000004432 carbon atom Chemical group C* 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
229910052757 nitrogen Inorganic materials 0.000 abstract 1
125000004433 nitrogen atom Chemical group N* 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/64—Oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyrrole Compounds (AREA)

NO994902A 1997-04-09 1999-10-08 Forebygging av brystkreft ved selektive östrogenreseptormodulatorer NO994902L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US4311897P	1997-04-09	1997-04-09
PCT/US1998/006989 WO1998045286A1 (en)	1997-04-09	1998-04-07	Prevention of breast cancer with selective estrogen receptor modulators

Publications (2)

Publication Number	Publication Date
NO994902D0 NO994902D0 (no)	1999-10-08
NO994902L true NO994902L (no)	1999-12-07

Family

ID=21925594

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO994902A NO994902L (no)	1997-04-09	1999-10-08	Forebygging av brystkreft ved selektive östrogenreseptormodulatorer

Country Status (15)

Country	Link
EP (1)	EP0975628A4 (id)
JP (1)	JP2001518897A (id)
KR (1)	KR20010006215A (id)
CN (1)	CN1259945A (id)
AU (1)	AU6957398A (id)
CA (1)	CA2286207A1 (id)
EA (1)	EA199900910A1 (id)
HU (1)	HUP0001845A2 (id)
ID (1)	ID23653A (id)
IL (1)	IL132279A0 (id)
NO (1)	NO994902L (id)
PL (1)	PL336206A1 (id)
TR (1)	TR199903244T2 (id)
WO (1)	WO1998045286A1 (id)
ZA (1)	ZA982818B (id)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6653479B1 (en)	1999-07-29	2003-11-25	Eli Lilly And Company	Crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b] thiophene hydrochloride
US6610706B1 (en)	1999-07-29	2003-08-26	Eli Lilly And Company	Crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride
SG185311A1 (en)	2007-10-16	2012-11-29	Repros Therapeutics Inc	Trans-clomiphene for metabolic syndrome
US20150031656A1 (en)	2012-02-29	2015-01-29	Repros Therapeutics Inc.	Combination therapy for treating androgen deficiency
HUE039052T2 (hu)	2013-02-19	2018-12-28	Novartis Ag	Benzotiofénszármazékok és azok készítményei szelektív ösztrogén receptor lebontóként
GB201311888D0 (en) *	2013-07-03	2013-08-14	Glaxosmithkline Ip Dev Ltd	Novel compounds
EP3373967B9 (en)	2015-11-10	2023-10-04	Paracrine Therapeutics AB	Treatment of er-negative breast cancer with an pdgf-cc inhibitor and an anti estrogen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR003930A1 (es) *	1995-02-28	1998-09-30	Lilly Co Eli	Procedimiento para preparar compuestos de 2-fenil-3-fenoxi o feniltio-benzotiofeno y sales farmaceuticamente aceptables, compuestos intermediarios de aplicación exclusiva en dicho procedimiento y metodo para preparar los compuestos intermediarios mencionados
US5510357A (en) *	1995-02-28	1996-04-23	Eli Lilly And Company	Benzothiophene compounds as anti-estrogenic agents
US5731342A (en) *	1996-02-22	1998-03-24	Eli Lilly And Company	Benzothiophenes, formulations containing same, and methods

1998
- 1998-04-02 ZA ZA9802818A patent/ZA982818B/xx unknown
- 1998-04-07 CA CA002286207A patent/CA2286207A1/en not_active Abandoned
- 1998-04-07 EA EA199900910A patent/EA199900910A1/ru unknown
- 1998-04-07 CN CN98805957A patent/CN1259945A/zh active Pending
- 1998-04-07 IL IL13227998A patent/IL132279A0/xx unknown
- 1998-04-07 PL PL98336206A patent/PL336206A1/xx unknown
- 1998-04-07 TR TR1999/03244T patent/TR199903244T2/xx unknown
- 1998-04-07 EP EP98915368A patent/EP0975628A4/en not_active Withdrawn
- 1998-04-07 KR KR1019997009295A patent/KR20010006215A/ko not_active Withdrawn
- 1998-04-07 HU HU0001845A patent/HUP0001845A2/hu unknown
- 1998-04-07 ID IDW991189A patent/ID23653A/id unknown
- 1998-04-07 AU AU69573/98A patent/AU6957398A/en not_active Abandoned
- 1998-04-07 WO PCT/US1998/006989 patent/WO1998045286A1/en not_active Ceased
- 1998-04-07 JP JP54309098A patent/JP2001518897A/ja active Pending
1999
- 1999-10-08 NO NO994902A patent/NO994902L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
ID23653A (id)	2000-05-11
EA199900910A1 (ru)	2000-04-24
AU6957398A (en)	1998-10-30
EP0975628A4 (en)	2001-03-21
KR20010006215A (ko)	2001-01-26
IL132279A0 (en)	2001-03-19
JP2001518897A (ja)	2001-10-16
NO994902D0 (no)	1999-10-08
TR199903244T2 (xx)	2000-05-22
HUP0001845A2 (hu)	2001-06-28
PL336206A1 (en)	2000-06-05
ZA982818B (en)	1999-10-04
WO1998045286A1 (en)	1998-10-15
CA2286207A1 (en)	1998-10-15
CN1259945A (zh)	2000-07-12
EP0975628A1 (en)	2000-02-02

Similar Documents

Publication	Publication Date	Title
NO994901L (no)	1999-12-09	Behandling av sentralnerveforstyrrelser ved selektive östrogenreseptormodulatorer
DE69523169D1 (de)	2001-11-15	Verwendung von Mangiferin oder seinen Derivaten zur kosmetischen Anwendung
TW200420542A (en)	2004-10-16	A compound having TGF β inhibition activity and a medicinal composition containing the same
IL142649A0 (en)	2002-03-10	Azole derivatives
HUP0001192A2 (hu)	2000-11-28	Topiramát és származékainak alkalmazása elhízás kezelésére használható gyógyszerkészítmények előállítására
LU93229I2 (fr)	2016-11-21	"pitolisant et ses sels pharmaceutiquement acceptables, tel que chlorhydrate"
MX9800577A (es)	1998-04-30	Derivados de 4,5-diaril oxazol.
DE69516866D1 (de)	2000-06-15	Stereochemische wortmanninderivate
ATE211732T1 (de)	2002-01-15	N-benzylpiperidin- und tetrahydropyridin-derivate
DK166383C (da)	1993-09-27	N-phenyl-benzamidderivater, fremgangsmaade til fremstilling heraf samt farmaceutiske praeparater indeholdende disse
NO307301B1 (no)	2000-03-13	Anvendelse av en forbindelse for fremstilling av et medikament for å inhibere steroidsulfataseaktivitet
NO304379B1 (no)	1998-12-07	11,21-bisfenyl-19-norpregnan-derivater, anvendelse derav og farmas°ytiske preparater inneholdende slike derivater
NZ313185A (en)	2000-05-26	2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives
GB9718903D0 (en)	1997-11-12	Method,compositions and kits for increasing the oral bioavailability of pharmaceutical agents
ES2123546T3 (es)	1999-01-16	Uso de derivados de 1-(aminoalquil)-3-quinoxalina-2-ona para la preparacion de composiciones neuroprotectoras.
BR0011865A (pt)	2006-06-06	derivados aromáticos e heterocìclicos de fitoteróis e/ou fitostanóis para uso no tratamento e prevenção de doença cardiovascular
NO994903L (no)	1999-12-09	Behandling eller profylakse av prostatakreft og benign prostatahyperplasi med selektive östrogenreseptormodulatorer
MX9805023A (es)	1998-11-30	Derivados de 1-metilcarbapenem.
PT71949A (en)	1981-08-19	Process for the preparation of new derivatives of 6,7-benzomorphan having pharmaceutical effect
TR199900286A2 (xx)	1999-09-21	Pirolidin ve piperidin t�revleri.
NO983444L (no)	1998-07-24	Benzo(c)kinolizin derivater, deres fremstilling og anvendelse som 5<alfa>-reduktaseinhibitorer
EA199900910A1 (ru)	2000-04-24	Профилактика рака молочной железы селективными модуляторами рецепторов эстрогена
IL100955A (en)	1997-03-18	Amino-polyhydroxy- cyclopentane derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same
DK1163258T3 (da)	2003-03-31	Derivater af 22R-hydroxycholesta-8, 14-dien til inhiberingen af meiosis
NO975560L (no)	1998-01-26	Fremgangsmåte for å redusere bentap

Legal Events

Date	Code	Title	Description
2001-12-27	FC2A	Withdrawal, rejection or dismissal of laid open patent application